Article
Author(s):
Columbus, OH-Age-adjusted approaches are needed for the evaluation and management of suspected orbital fracture in pediatric patients because children are different from adults, according to Jill A. Foster, MD.
Alkeus Pharmaceuticals receives FDA Rare Pediatric Disease and Fast Track designations for gildeuretinol as treatment for Stargardt disease
ROP: Treating and preventing blindness in preterm babies
Study explores the true costs of treating pediatric cataracts
Managing a changing landscape of IRD pediatric cases
Cerebral visual impairment: A growing concern in pediatric vision loss
Factors affecting ROP development in the 8 weeks following birth